Clinical Trials
3 trialsNCT05733312 2026-01-30
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
Mayo Clinic
Phase NA Recruiting
NCT00761280 2014-11-14
SAPPHIRE
Isarna Therapeutics GmbH
Phase 3 Terminated
NCT00431561 2013-12-03
Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
Isarna Therapeutics GmbH
Phase 2 Completed